Sarepta Therapeutics to Present at the 26th Annual Credit Suisse Healthcare Conference
CAMBRIDGE, Mass., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicines to treat rare neuromuscular diseases, today …